
Mercury Protest: Mercury-free activists protest the continuing FDA approval of mercury in dental amalgam fillings.
The FDA's controversial 2009 Final Rule upholding the safety of dental amalgam sparked a public outcry and prompted several groups - dental professionals as well as citizens - to file legal petitions for reconsideration with the FDA.
According to FDA watchdog Jim Dickinson of Fdaweb.com, the FDA appears ready to reverse itself this time.
"They're laying the groundwork to make a reversal appear legally consistent," he said, referring to FDA's interest in considering information previously overlooked as well as a 2009 report on risk assessment by the National Academy of Sciences. "It appears the agency is aware that it's on the losing side, and as the scientific evidence grows, it's time to move."
On the other hand, "FDA hopes to defer to its dental products advisory panel, thus much depends on who gets named to the panel and whether they're up to the job," warned Jim Love, attorney for the International Academy of Oral Medicine and Toxicology (IAOMT), an anti-mercury dental association sponsoring two of the four legal petitions.













Comment: For more information about Bisphenol A (BPA) and the surrounding controversy read the following articles listed below:
The Real Story Behind Bisphenol A
Bisphenol A, Chemical Used to Make Plastic, Lingers in Body
BPA Report Details Chemical's Hazards
Scientists Believe BPA is Risky - it's Just a Matter of Agreeing on How Much
President's Cancer Panel Warns of Toxic Effects of BPA
Study: Human Exposure to BPA 'Grossly Underestimated'
BPA Should Be Avoided, Federal Official Says
FDA is Sued for Failing to Regulate Bisphenol A